Hello,
Welcome to Insider Healthcare. I'm Lydia Ramsey Pflanzer, and today in healthcare news:
- Meet Mirvie, a startup developing a blood test to detect pregnancy complications;
- Sen. Klobuchar's thoughts on M&A should worry Big Pharma;
- Cigna's working with Ginger to expand mental-health access to its members.
If you're new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @lydiaramsey125. Let's get to it…
Mirvie cofounder Maneesh Jain (right).
Mirvie
Mirvie
A former Grail exec and the president of the Chan-Zuckerberg Initiative are developing a blood test to help expectant mothers understand the chances of pregnancy complications
- Mirvie is developing a blood test for expectant mothers to predict pregnancy complications.
- It was founded in 2018 by former Grail exec Maneesh Jain and Chan Zuckerberg Biohub President Dr. Stephen Quake.
- The company is conducting clinical trials and plans to apply for approval for its liquid biopsy tests.
Samuel Corum/Pool/AFP
3 takeaways from a top Democratic senator's new book on monopolies that should have Big Pharma worried
- Sen. Amy Klobuchar is calling for an overhaul of US M&A and monopoly policies in a new book.
- The Federal Trade Commission, meanwhile, has begun more heavily scrutinizing biopharma M&A.
- Funds such as BlackRock and Fidelity owning shares in competing firms harms competition, she says.
Ginger provides mental health coaching through its app.
Ginger
Ginger
One of the nation's biggest insurers wants to make mental-health care available to more people. Here's how Cigna plans to tap Ginger's network of coaches to do it.
- Cigna is partnering with mental-health care startup Ginger to offer its services to Cigna members.
- Patients will have access to Ginger's network of mental health coaches and therapists.
- Ginger believes its coaches could help alleviate the pandemic-induced demand placed on licensed therapists.
More stories we're reading:
- CDC: Fully vaccinated people can go maskless outside to exercise, dine, or socialize (Insider)
- Vaccine resistance might not be the reason for the recent vaccination plateau (Stat News)
- How SPAC insiders can make millions even if the company they take public - in this case a healthcare services company - falters (The Wall Street Journal)
- The CEO of major health insurer Humana, which is buying Kindred, laid out why he's betting big on primary care (Insider)
- The COVID-19 vaccine side effects to expect if you're in your 20s or 30s (Insider)
- Lydia
Read the original article on Business Insider